EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efficacy of Methotrexate Treatment in Women with Tubal Ectopic Pregnancy, University Hospital, Tripoli, Libya

Noura Elawam

Razi Medical Journal · 2026

DOI: 10.69667/rmj.26320 ↗
AbstractBibliografische Angaben

Abstract

The use of methotrexate for the treatment of women with tubal ectopic pregnancies is now common practice. However, the clinical and hormonal determinants of the success of this treatment are not known. Methods: We studied 120 women with tubal ectopic pregnancies who were treated with methotrexate intramuscularly according to a single-dose protocol. Pretreatment serum concentrations of human chorionic gonadotropin and progesterone, the size and volume of the gestational mass, fetal cardiac activity, and the presence of fluid (presumably blood) in the peritoneal cavity were correlated with the efficacy of therapy, as defined by resolution of the ectopic pregnancy without the need for surgical intervention. There was no relation between the women’s age or parity, the size or volume of the conceptus, or the presence of fluid in the peritoneal cavity and the efficacy of treatment. Among the 110 women in whom treatment was successful (91.6 percent), the mean (±SD) serum chorionic gonadotropin and progesterone concentrations were 4019±6362 mIU per milliliter and 6.9±6.7 ng per milliliter (21.9±21.3 nmol per liter), respectively, as compared with 13,420± 16,590 mIU per milliliter and 10.2±5.5 ng per milliliter (32.4±17.5 nmol per liter) (P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →